IRONWOOD PHARMACEUTICALS, INC.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-860.0K | $-4.2M | $-1.1M | $15.3M | $-1.06B | $45.7M | $48.9M | $50.3M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $506.0K | $513.0K | $512.0K | $507.0K | $270.0K | $286.0K | $340.0K | $363.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $8.6M | $8.4M | $8.7M | $7.9M | $8.3M | $7.1M | $7.3M | $7.1M |
| Net Cash from Operating Activities | $33.5M | $45.0M | $35.8M | $32.5M | $35.0M | $80.2M | $79.2M | $69.1M |
| Investing Activities | ||||||||
| Capital Expenditures | $58.0K | $68.0K | $211.0K | $49.0K | $0 | $13.0K | $-27.0K | $66.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-58.0K | $-68.0K | $-4.2M | $-22.6M | $-999.5M | $-13.0K | $27.0K | $-66.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | $0 | $0 |
| Net Cash from Financing Activities | $-49.4M | $-15.6M | $-50.9M | $-75.0M | $399.1M | $4.0M | $2.8M | $797.0K |
| Net Change in Cash | $-16.0M | $29.4M | $-19.3M | $-65.2M | $-565.5M | $84.1M | $82.0M | $69.8M |
| Free Cash Flow | $33.4M | $44.9M | $35.6M | $32.4M | $35.0M | $80.2M | $79.2M | $69.0M |